|
1
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2008. CA Cancer J Clin. 58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Foroni C, Broggini M, Generali D and Damia
G: Epithelial-mesenchymal transition and breast cancer: Role,
molecular mechanisms and clinical impact. Cancer Treat Rev.
38:689–697. 2012. View Article : Google Scholar
|
|
3
|
Drasin DJ, Robin TP and Ford HL: Breast
cancer epithelial-to-mesenchymal transition: Examining the
functional consequences of plasticity. Breast Cancer Res.
13:2262011. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jechlinger M, Grünert S and Beug H:
Mechanisms in epithelial plasticity and metastasis: insights from
3D cultures and expression profiling. J Mammary Gland Biol
Neoplasia. 7:415–432. 2002. View Article : Google Scholar
|
|
5
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nichols J, Zevnik B, Anastassiadis K, et
al: Formation of pluripotent stem cells in the mammalian embryo
depends on the POU transcription factor Oct4. Cell. 95:379–391.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hay DC, Sutherland L, Clark J and Burdon
T: Oct-4 knockdown induces similar patterns of endoderm and
trophoblast differentiation markers in human and mouse embryonic
stem cells. Stem Cells. 22:225–235. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Boiani M and Schöler HR: Regulatory
networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell
Biol. 6:872–884. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Monk M and Holding C: Human embryonic
genes re-expressed in cancer cells. Oncogene. 20:8085–8091. 2001.
View Article : Google Scholar
|
|
11
|
Chen YC, Hsu HS, Chen YW, et al: Oct-4
expression maintained cancer stem-like properties in lung
cancer-derived CD133-positive cells. PLoS One. 3:e26372008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim RJ and Nam JS: OCT4 expression
enhances features of cancer stem cells in a mouse model of breast
cancer. Lab Anim Res. 27:147–152. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Zhang X, Wang X, et al:
Inhibition of LDH-A by lentivirus-mediated small interfering RNA
suppresses intestinal-type gastric cancer tumorigenicity through
the downregulation of Oct4. Cancer Lett. 321:45–54. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Guo Y, Liu S, Wang P, et al: Expression
profile of embryonic stem cell-associated genes Oct4, Sox2 and
Nanog in human gliomas. Histopathology. 59:763–775. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Iida H, Suzuki M, Goitsuka R and Ueno H:
Hypoxia induces CD133 expression in human lung cancer cells by
up-regulation of OCT3/4 and SOX2. Int J Oncol. 40:71–79. 2012.
|
|
16
|
He W, Li K, Wang F, Qin YR and Fan QX:
Expression of OCT4 in human esophageal squamous cell carcinoma is
significantly associated with poorer prognosis. World J
Gastroenterol. 18:712–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schoenhals M, Kassambara A, De Vos J, et
al: Embryonic stem cell markers expression in cancers. Biochem
Biophys Res Commun. 383:157–162. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang X, Han B, Huang J, Zheng B, Geng Q,
Aziz F and Dong Q: Prognostic significance of OCT4 expression in
adenocarcinoma of the lung. Jpn J Clin Oncol. 40:961–966. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Moreira AL, Gonen M, Rekhtman N and Downey
RJ: Progenitor stem cell marker expression by pulmonary carcinomas.
Mod Pathol. 23:889–895. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li X, Wang J, Xu Z, et al: Expression of
sox2 and oct4 and their clinical significance in human
non-small-cell lung cancer. Int J Mol Sci. 13:7663–7675. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee W, Jiang Z, Liu J, et al: The mutation
spectrum revealed by paired genome sequences from a lung cancer
patient. Nature. 465:473–477. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Brabletz T, Hlubek F, Spaderna S, et al:
Invasion and metastasis in colorectal cancer:
Epithelial-mesenchymal transition, mesen-chymal-epithelial
transition, stemcells and beta-catenin. Cells Tissues Organs.
179:56–65. 2005. View Article : Google Scholar
|
|
23
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Satelli A and Li S: Vimentin in cancer and
its potential as a molecular target for cancer therapy. Cell Mol
Life Sci. 68:3033–3046. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mendez MG, Kojima S and Goldman RD:
Vimentin induces changes incell shape, motility, and adhesion
during the epithelial to mesenchymal transition. FASEB J.
24:1838–1851. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang X, Liu G, Kang Y, et al: N-cadherin
expression is associated with acquisition of EMT phenotype and with
enhanced invasion in erlotinib resistant lung cancer cell lines.
PLoS One. 8:e576922013. View Article : Google Scholar
|
|
27
|
König K, Meder L, Kröger C, et al: Loss of
the keratin cytoskeleton is not sufficient to induce epithelial
mesenchymal transition in a novel KRAS driven sporadic lung cancer
mouse model. PLoS One. 8:e579962013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gumbiner B, Stevenson B and Grimaldi A:
The role of the cell adhesion molecule uvomorulin in the formation
and maintenance of the epithelial junctional complex. J Cell Biol.
107:1575–1587. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Provost E and Rimm DL: Controversies at
the cytoplasmic face of the cadherin based adhesion complex. Curr
Opin Cell Biol. 11:567–572. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Morin PJ, Sparks AB, Korinek V, et al:
Activation of beta-catenin-Tcf signaling in colon cancer by
mutations in beta catenin or APC. Science. 275:1787–1790. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Korinek V, Barker N, Morin PJ, et al:
Constitutive transcriptional activation by a beta-catenin-Tcf
complex in APC-/colon carcinoma. Science. 275:1784–1787. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang J, Mani SA, Donaher JL, et al: Twist,
a master regulator of morphogenesis, plays an essential role in
tumor metastasis. Cell. 117:927–939. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bolós V, Peinado H, Pérez-Moreno MA, et
al: The transcription factor Slug represses E-cadherin expression
and induces epithelial to mesenchymal transitions: a comparison
with Snail and E47 repressors. J Cell Sci. 116:499–511. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Conacci-Sorrell M, Simcha I, Ben-Yedidia
T, et al: Autoregulation of E-cadherin expression by
cadherin-cadherin interactions: The roles of beta-catenin
signaling, Slug, and MAPK. J Cell Biol. 163:847–857. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sommers CL, Gelmann EP, Kemler R, et al:
Alterations in beta-catenin phosphorylation and plakoglobin
expression in human breast cancer cells. Cancer Res. 54:3544–3552.
1994.PubMed/NCBI
|
